Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.

about

Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.

Item

http://www.wikidata.org/entity/Q55501318

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.

@en

Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.

@nl

type

Item

label

Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.

@en

Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.

@nl

prefLabel

Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.

@en

Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.

@nl

P1476

Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.

@en

P2093

Il Han Song

http://www.w3.org/2001/XMLSchema#string

So Mi Kim

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Extrahepatic manifestations of chronic hepatitis C virus infection

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

Regulation of GLUT4 expression in vivo and in vitro

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

Global epidemiology and burden of HCV infection and HCV-related disease.

Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis.

Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.

Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients.

Hepatitis C virus associated glomerulopathies.

Side effects of therapy of hepatitis C and their management.

P304

670-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3904/KJIM.2018.202

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29961309

http://www.w3.org/2001/XMLSchema#string

P921

chronic kidney disease

Añaw

P932

6030406

http://www.w3.org/2001/XMLSchema#string